1: Schuster RK, Mustafa MB, Baskar JV, Rosentel J, Chester ST, Knaus M. Efficacy 
of a topical combination of fipronil, (S)-methoprene, eprinomectin and 
praziquantel (Broadline(®)) against naturally acquired infections with cestodes 
of the genus Joyeuxiella in cats. Parasitol Res. 2016 Mar 30. [Epub ahead of 
print] PubMed PMID: 27026504.

2: Giri BR, Roy B. Praziquantel induced oxidative stress and apoptosis-like cell 
death in Raillietina echinobothrida. Acta Trop. 2016 Mar 19;159:50-57. doi: 
10.1016/j.actatropica.2016.03.022. [Epub ahead of print] PubMed PMID: 27005397.

3: Clède S, Cowan N, Lambert F, Bertrand HC, Rubbiani R, Patra M, Hess J, Sandt 
C, Trcera N, Gasser G, Keiser J, Policar C. Bimodal X-ray and Infrared Imaging of 
an Organometallic Derivative of Praziquantel in Schistosoma Mansoni. Chembiochem. 
2016 Mar 15. doi: 10.1002/cbic.201500688. [Epub ahead of print] PubMed PMID: 
26991635.

4: Garcia HH, Lescano AG, Gonzales I, Bustos JA, Pretell EJ, Horton J, Saavedra 
H, Gonzalez AE, Gilman RH; Cysticercosis Working Group in Peru. Cysticidal 
Efficacy of Combined Treatment with Praziquantel and Albendazole for Parenchymal 
Brain Cysticercosis. Clin Infect Dis. 2016 Mar 16. pii: ciw134. [Epub ahead of 
print] PubMed PMID: 26984901.

5: Barbosa LM, Reis EA, Dos Santos CR, Costa JM, Carmo TM, Aminu PT, Pitanga TN, 
Ponce-Terashima R, Blank WA, Silva LK, Reis MG, Blanton RE. Repeated praziquantel 
treatments remodel the genetic and spatial landscape of schistosomiasis risk and 
transmission. Int J Parasitol. 2016 Mar 4. pii: S0020-7519(16)00056-4. doi: 
10.1016/j.ijpara.2016.01.007. [Epub ahead of print] PubMed PMID: 26953255.

6: Senghor B, Diaw OT, Doucoure S, Seye M, Diallo A, Talla I, Bâ CT, Sokhna C. 
Impact of Annual Praziquantel Treatment on Urogenital Schistosomiasis in a 
Seasonal Transmission Focus in Central Senegal. PLoS Negl Trop Dis. 2016 Mar 
25;10(3):e0004557. doi: 10.1371/journal.pntd.0004557. eCollection 2016 Mar. 
PubMed PMID: 27015646.

7: Onkanga IO, Mwinzi PN, Muchiri G, Andiego K, Omedo M, Karanja DM, Wiegand RE, 
Secor WE, Montgomery SP. Impact of two rounds of praziquantel mass drug 
administration on Schistosoma mansoni infection prevalence and intensity: a 
comparison between community wide treatment and school based treatment in western 
Kenya. Int J Parasitol. 2016 Mar 2. pii: S0020-7519(16)00040-0. doi: 
10.1016/j.ijpara.2016.01.006. [Epub ahead of print] PubMed PMID: 26940547.

8: Cvejic D, Schneider C, Fourie J, de Vos C, Bonneau S, Bernachon N, Hellmann K. 
Efficacy of a single dose of milbemycin oxime/praziquantel combination tablets, 
Milpro(®), against adult Echinococcus multilocularis in dogs and both adult and 
immature E. multilocularis in young cats. Parasitol Res. 2016 
Mar;115(3):1195-202. doi: 10.1007/s00436-015-4855-7. Epub 2015 Dec 11. PubMed 
PMID: 26660919; PubMed Central PMCID: PMC4759226.

9: Hammam OA, Elkhafif N, Attia YM, Mansour MT, Elmazar MM, Abdelsalam RM, Kenawy 
SA, El-Khatib AS. Wharton's jelly-derived mesenchymal stem cells combined with 
praziquantel as a potential therapy for Schistosoma mansoni-induced liver 
fibrosis. Sci Rep. 2016 Feb 15;6:21005. doi: 10.1038/srep21005. PubMed PMID: 
26876222; PubMed Central PMCID: PMC4753476.

10: Olveda RM, Acosta LP, Tallo V, Baltazar PI, Lesiguez JL, Estanislao GG, Ayaso 
EB, Monterde DB, Ida A, Watson N, McDonald EA, Wu HW, Kurtis JD, Friedman JF. 
Efficacy and safety of praziquantel for the treatment of human schistosomiasis 
during pregnancy: a phase 2, randomised, double-blind, placebo-controlled trial. 
Lancet Infect Dis. 2016 Feb;16(2):199-208. doi: 10.1016/S1473-3099(15)00345-X. 
Epub 2015 Nov 2. PubMed PMID: 26511959; PubMed Central PMCID: PMC4752899.

11: Havlíková L, Šatínský D, Solich P. Aspects of decontamination of ivermectin 
and praziquantel from environmental waters using advanced oxidation technology. 
Chemosphere. 2016 Feb;144:21-8. doi: 10.1016/j.chemosphere.2015.08.039. Epub 2015 
Sep 4. PubMed PMID: 26344145.

12: Forwood JM, Bubner EJ, Landos M, D'Antignana T, Deveney MR. Praziquantel 
treatment for yellowtail kingfish (Seriola lalandi): dose and duration safety 
study. Fish Physiol Biochem. 2016 Feb;42(1):103-9. doi: 
10.1007/s10695-015-0121-2. Epub 2015 Aug 28. PubMed PMID: 26314575.

13: Saengsawang P, Promthet S, Bradshaw P. Reinfection by Opisthorchis Viverrini 
after Treatment with Praziquantel. Asian Pac J Cancer Prev. 2016;17(2):857-62. 
PubMed PMID: 26925692.

14: Mendonça AM, Feitosa AP, Veras DL, Matos-Rocha TJ, Cavalcanti MG, Barbosa CC, 
Brayner FA, Alves LC. THE SUSCEPTIBILITY OF RECENT ISOLATES OF Schistosoma 
mansoni TO PRAZIQUANTEL. Rev Inst Med Trop Sao Paulo. 2016;58. pii: 
S0036-46652016005000206. doi: 10.1590/S1678-9946201658007. Epub 2016 Feb 23. 
PubMed PMID: 26910445.

15: Knopp S, Person B, Ame SM, Ali SM, Muhsin J, Juma S, Khamis IS, Rabone M, 
Blair L, Fenwick A, Mohammed KA, Rollinson D. Praziquantel coverage in schools 
and communities targeted for the elimination of urogenital schistosomiasis in 
Zanzibar: a cross-sectional survey. Parasit Vectors. 2016 Jan 4;9(1):5. doi: 
10.1186/s13071-015-1244-0. PubMed PMID: 26727915; PubMed Central PMCID: 
PMC4700672.

16: Charoensuk L, Pinlaor P, Wanichwecharungruang S, Intuyod K, Vaeteewoottacharn 
K, Chaidee A, Yongvanit P, Pairojkul C, Suwannateep N, Pinlaor S. 
Nanoencapsulated curcumin and praziquantel treatment reduces periductal fibrosis 
and attenuates bile canalicular abnormalities in Opisthorchis viverrini-infected 
hamsters. Nanomedicine. 2016 Jan;12(1):21-32. doi: 10.1016/j.nano.2015.10.005. 
Epub 2015 Nov 2. PubMed PMID: 26542278.

17: Chami GF, Kontoleon AA, Bulte E, Fenwick A, Kabatereine NB, Tukahebwa EM, 
Dunne DW. Profiling Nonrecipients of Mass Drug Administration for Schistosomiasis 
and Hookworm Infections: A Comprehensive Analysis of Praziquantel and Albendazole 
Coverage in Community-Directed Treatment in Uganda. Clin Infect Dis. 2016 Jan 
15;62(2):200-7. doi: 10.1093/cid/civ829. Epub 2015 Sep 25. PubMed PMID: 26409064; 
PubMed Central PMCID: PMC4690482.

18: Walker M, Mabud TS, Olliaro PL, Coulibaly JT, King CH, Raso G, Scherrer AU, 
Stothard JR, Sousa-Figueiredo JC, Stete K, Utzinger J, Basáñez MG. New approaches 
to measuring anthelminthic drug efficacy: parasitological responses of childhood 
schistosome infections to treatment with praziquantel. Parasit Vectors. 2016 Jan 
27;9(1):41. doi: 10.1186/s13071-016-1312-0. PubMed PMID: 26813154; PubMed Central 
PMCID: PMC4728951.

19: Assaré RK, Tian-Bi YN, Yao PK, N'Guessan NA, Ouattara M, Yapi A, Coulibaly 
JT, Meïté A, Hürlimann E, Knopp S, Utzinger J, N'Goran EK. Sustaining Control of 
Schistosomiasis Mansoni in Western Côte d'Ivoire: Results from a SCORE Study, One 
Year after Initial Praziquantel Administration. PLoS Negl Trop Dis. 2016 Jan 
20;10(1):e0004329. doi: 10.1371/journal.pntd.0004329. eCollection 2016 Jan. 
PubMed PMID: 26789749; PubMed Central PMCID: PMC4720284.

20: Meister I, Leonidova A, Kovač J, Duthaler U, Keiser J, Huwyler J. Development 
and validation of an enantioselective LC-MS/MS method for the analysis of the 
anthelmintic drug praziquantel and its main metabolite in human plasma, blood and 
dried blood spots. J Pharm Biomed Anal. 2016 Jan 25;118:81-8. doi: 
10.1016/j.jpba.2015.10.011. Epub 2015 Oct 22. PubMed PMID: 26517852.